   Professor Karl Claxton    B_AO1_R_N March 1967     IH1_Z AH0 HH_EH1_L_TH IH0_K_AA1_N_AH0_M_IH0_S_T AE1_T DH_AH0 University AH1_V York He HH_AE1_Z AH0 PhD IH0_N Economics    AH0 MSc IH0_N Health Economics AH0_N_D AH0 BA IH0_N Economics F_R_AH1_M DH_AH0 University AH1_V York He W_AA1_Z AH0 Harkness Fellow AE1_T DH_AH0 Harvard Chan School AH1_V Public Health AH0_N_D F_R_AH1_M 1999 AH0_N_T_IH1_L 2007 HH_IY1 HH_EH1_L_D AE1_N AE1_JH_AH2_NG_K_T AH0_P_OY1_N_T_M_AH0_N_T DH_EH1_R AE1_Z AE1_N Assistant Professor AH1_V Health AH0_N_D Decision Sciences    He HH_AE1_Z B_IH1_N AH0 M_EH1_M_B_ER0 AH1_V DH_AH0 National Institute F_AO1_R Health AH0_N_D Care Excellence Appraisal Committee S_IH1_N_S 1999 He IH1_Z K_OW1 EH1_D_AH0_T_ER0 AH1_V DH_AH0 Journal AH1_V Health Economics He W_AA1_Z D_IH0_S_K_R_AY1_B_D B_AY1 DH_AH0 Financial Times IH0_N 2015 AE1_Z P_AA1_S_AH0_B_L_IY0 DH_AH0 M_OW1_S_T D_EY1_N_JH_ER0_AH0_S M_AE1_N IH0_N EH2_K_AH0_N_AA1_M_IH0_K_S F_AO1_R F_AA2_R_M_AH0_S_UW1_T_IH0_K_AH0_L K_AH1_M_P_AH0_N_IY2_Z B_IH0_K_AO1_Z HH_IH1_Z    W_ER1_K AA1_N DH_AH0 K_AA1_S_T IH0_F_EH1_K_T_IH0_V_N_AH0_S AH1_V M_EH1_D_AH0_S_AH0_N_Z IH1_Z IH1_N_F_L_UW2_AH0_N_S_IH0_NG P_AA1_L_AH0_S_IY0 W_EH1_L B_IH0_AA1_N_D DH_AH0 UK    He W_AA1_Z AH0 JH_OY1_N_T AO1_TH_ER0 AH1_V AH0 P_EY1_P_ER0 AA1_N DH_AH0 Sustainable Development Goals P_AH1_B_L_IH0_SH_T IH0_N Nature IH0_N July 2015 He S_EH1_Z DH_AH0 Cancer Drugs Fund SH_UH1_D B_IY1 S_K_R_AE1_P_T B_IH0_K_AO1_Z DH_AH0 M_AH1_N_IY0 W_UH1_D B_IY1 B_EH1_T_ER0 Y_UW1_Z_D AA1_N 21 000 P_EY1_SH_AH0_N_T_S W_IH1_DH HH_AA1_R_T    L_AH1_NG AH0_N_D G_AE1_S_T_R_OW0 IH2_N_T_EH1_S_T_IH0_N_AH0_L D_IH0_Z_IY1_Z_AH0_Z HH_UW1 AA1_R D_IH0_N_AY1_D K_AA1_S_T IH0_F_EH1_K_T_IH0_V EH1_V_AH0_D_AH0_N_S B_EY1_S_T T_R_IY1_T_M_AH0_N_T    He W_AA1_Z DH_AH0 AO1_TH_ER0 AO1_R AH0 R_IY0_P_AO1_R_T S_EY1_IH0_NG DH_AE1_T DH_AH0 M_AE1_K_S_AH0_M_AH0_M TH_R_EH1_SH_OW2_L_D    K_ER1_AH0_N_T_L_IY0 ER0_AW1_N_D  £ 30 000 AH0 Y_IH1_R Y_UW1_Z_D B_AY1 National Institute F_AO1_R Health AH0_N_D Care Excellence    F_AO1_R JH_AH1_JH_IH0_NG AH0 M_EH1_D_AH0_S_AH0_N K_AA1_S_T IH0_F_EH1_K_T_IH0_V SH_UH1_D B_IY1 M_AO1_R DH_AE1_N HH_AE1_V_D The R_IY0_P_AO1_R_T F_AW1_N_D DH_AE1_T EH1_N_IY0 IH2_N_T_ER0_V_EH1_N_SH_AH0_N K_AO1_S_T_IH0_NG M_AO1_R DH_AE1_N  £ 13 000 P_ER1 Quality AH0_JH_AH1_S_T_IH0_D L_AY1_F Y_IH1_R R_IH1_S_K_T K_AA1_Z_IH0_NG M_AO1_R HH_AA1_R_M DH_AE1_N G_UH1_D B_AY1 D_IH0_N_AY1_IH0_NG K_AA1_S_T IH0_F_EH1_K_T_IH0_V T_R_IY1_T_M_AH0_N_T T_UW1 AH1_DH_ER0 P_EY1_SH_AH0_N_T_S    Development G_OW1_L_Z SH_UH1_D EH0_N_EY1_B_AH0_L D_IH0_S_IH1_ZH_AH0_N M_EY1_K_IH0_NG     Keith Shepherd    Douglas Hubbard    Norman Fenton    Karl Claxton    Eike Luedeling  &  Jan D_IY1 Leeuw    Nature July 2015